S

Sail Biomedicines

In vivo programmable RNA CAR-T therapies

Research Associate 1/Research Associate 2 - Preclinical Manufacturing

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$75k - $100kIn-person

About the Job

Requirements

  • A B.S. in Molecular Biology, Biochemistry, Biochemical Engineering, or a related field with 2+ years of industry experience, or an M.S. in one of these fields.
  • Hands-on experience in one or more of RNA/DNA production and purification, lipid nanoparticle formulation and characterization, chromatography such as AKTA/FPLC or HPLC, tangential flow filtration, or automated liquid handling systems.
  • Strong understanding of experimental design, data analysis, and technical documentation.
  • Proficiency in core laboratory techniques, including aseptic technique, buffer preparation, and instrument operation or programming.

Responsibilities

  • Support production of RNA cargo molecules and lipid nanoparticle formulations for preclinical studies.
  • Perform hands-on laboratory work involving eRNA synthesis, purification, and lipid nanoparticle encapsulation.
  • Contribute to development, optimization, and scale-up of high-yield, high-quality RNA and lipid nanoparticle processes.
  • Operate and maintain lab-scale instrumentation, including AKTA (FPLC), tangential flow filtration systems, PCR, HPLC, capillary electrophoresis, UV-Vis, and light scattering platforms.
  • Perform analytical characterization and quantification of RNA and other nucleic acids.
  • Analyze experimental data and document results in electronic lab notebooks and technical reports.
  • Collaborate with research, analytical, and process development teams to support project goals.

Desired Qualifications

  • Experience with analytical methods such as capillary electrophoresis, UV-Vis, or light scattering is preferred.
  • Strong organizational and documentation skills.
  • Ability to work independently and collaboratively.
  • Ability to clearly present technical data and insights.

About the Company

Sail Biomedicines

In vivo programmable RNA CAR-T therapies

Sail Biomedicines creates programmable RNA medicines that enable in vivo CAR-T therapies for autoimmune diseases, turning the patient’s body into the site of T-cell engineering. Its platform combines Endless RNA circular RNA, a library of targeted nanoparticles for cell-specific delivery, and AI-powered design tools to program T cells inside the body. It differentiates from competitors by delivering and programming CAR-T cells in vivo rather than via ex vivo cell manufacturing, leveraging circular RNA and targeted nanoparticles, with support from its Flagship Pioneering lineage and a Johnson & Johnson collaboration. The goal is to provide scalable, durable immune resets and remission for immune-mediated diseases with broader, more accessible treatments.

Company size
51-200
Company stage
Acquired
Total funding
Not listed
Headquarters
United States
Founded
2023

Recently Posted Jobs

Explore more opportunities at Sail Biomedicines

See more jobs